MedPlus Health Services Limited
National Stock Exchange of IndiaTotal Valuation
MedPlus Health Services Limited carries a market capitalization of 98.73B, placing it among publicly traded companies globally. Its enterprise value stands at 107.98B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 98.73B |
| Enterprise Value | 107.98B |
Valuation Ratios
MedPlus Health Services Limited trades at a trailing price-to-earnings ratio of 60.56.
| PE Ratio | 60.56 |
| PS Ratio | 1.74 |
| PB Ratio | N/A |
| P/TBV Ratio | N/A |
| P/FCF Ratio | N/A |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, MedPlus Health Services Limited trades at an EV/EBITDA multiple of 40.20 and an EV/FCF ratio of 125.59. The EV/Sales ratio of 1.74 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 40.20 provides insight into valuation relative to core operating earnings.
| EV / Sales | 1.74 |
| EV / EBITDA | 40.20 |
| EV / EBIT | 40.20 |
| EV / FCF | 125.59 |
Financial Position
MedPlus Health Services Limited maintains a current ratio of 6.24, meaning it holds 6.2x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 127.32, indicating elevated leverage, while an interest coverage ratio of 2.55 demonstrates limited ability to service its debt obligations.
| Current Ratio | 6.24 |
| Quick Ratio | 1.30 |
| Debt / Equity | 127.32 |
| Debt / EBITDA | N/A |
| Interest Coverage | 2.55 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | N/A |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | 29.29 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Taxes
Over the trailing twelve months, MedPlus Health Services Limited has paid 400.34M in income taxes, reflecting an effective tax rate of 18.34.
| Income Tax | 400.34M |
| Effective Tax Rate | 18.34 |
Stock Price Statistics
MedPlus Health Services Limited's stock has declined approximately -4.46226% over the past 52 weeks. The 50-day moving average sits at 872.19, while the 200-day moving average is 828.21.
| Beta (5Y) | N/A |
| 52-Week Price Change | -4.46226% |
| 50-Day Moving Average | 872.19 |
| 200-Day Moving Average | 828.21 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, MedPlus Health Services Limited generated 61.90B in revenue and converted that into 1.78B in net income, yielding earnings per share of 14.87. EBITDA reached 2.69B, while operating income came in at 2.69B.
| Revenue | 61.90B |
| Gross Profit | 15.69B |
| Operating Income | 2.69B |
| Pretax Income | 2.18B |
| Net Income | 1.78B |
| EBITDA | 2.69B |
| EBIT | 2.69B |
| Earnings Per Share (EPS) | 14.87 |
Margins
MedPlus Health Services Limited operates with a gross margin of 25.35, reflecting its pricing power and cost economics. The operating margin of 4.34 and net profit margin of 2.88 provide insight into operational efficiency.
| Gross Margin | 25.35 |
| Operating Margin | 4.34 |
| Pretax Margin | 3.53 |
| Profit Margin | 2.88 |
| EBITDA Margin | 4.34 |
Scores
MedPlus Health Services Limited posts an Altman Z-Score of 11.79, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 11.79 |